Search Results for: IL6R

Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
Novel IVL involucrin
  • Formation of the cornified envelope
  • Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
Novel MCL1 MCL1 apoptosis regulator, BCL2 family member
  • Interleukin-4 and Interleukin-13 signaling
  • Signaling by ALK fusions and activated point mutants
Novel PEX1 peroxisomal biogenesis factor 1
  • Peroxisomal protein import
  • Peroxisomal protein import
  • Zellweger syndrome spectrum, including: Zellweger syndrome (ZS); Adrenoleukodystrophy, neonatal (NALD); Infantile Refsum disease (IRD)
Novel SLC39A2 solute carrier family 39 member 2
  • Zinc influx into cells by the SLC39 gene family
ADRB2 adrenoceptor beta 2
  • Adrenoceptors
  • G alpha (s) signalling events
  • Ub-specific processing proteases
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • Spermine
  • Amphetamine
  • Betaxolol
  • Bethanidine
  • Isoetharine
  • Cabergoline
  • Metoprolol
  • Metoprolol
  • Olanzapine
  • Atenolol
  • Norepinephrine
  • Timolol
  • Phenylpropanolamine
  • Dipivefrin
  • Sotalol
  • Carteolol
  • Nortriptyline
  • Propranolol
  • Labetalol
  • Bisoprolol
  • Epinephrine
  • Paroxetine
  • Trimipramine
  • Cryptenamine
  • Orciprenaline
  • Dobutamine
  • Pseudoephedrine
  • Alprenolol
  • Ritodrine
  • Ritodrine
  • Terbutaline
  • Bitolterol
  • Phenoxybenzamine
  • Salmeterol
  • Pindolol
  • Formoterol
  • Salbutamol
  • Ergoloid mesylate
  • Isoprenaline
  • Arbutamine
  • Amiodarone
  • Carvedilol
  • Desipramine
  • Propafenone
  • Acebutolol
  • Nadolol
  • Levobunolol
  • Metipranolol
  • Aripiprazole
  • Arformoterol
  • Fenoterol
  • Pirbuterol
  • Bevantolol
  • Penbutolol
  • Ephedra sinica root
  • Ephedrine
  • Mephentermine
  • Procaterol
  • Clenbuterol
  • Bambuterol
  • Oxprenolol
  • Putrescine
  • Spermidine
  • Celiprolol
  • Nebivolol
  • Indacaterol
  • Bedoradrine
  • NCX 950
  • Asenapine
  • Droxidopa
  • Bufuralol
  • Protokylol
  • (S)-carazolol
  • Bopindolol
  • Bupranolol
  • Befunolol
  • Olodaterol
  • Vilanterol
  • Viloxazine
  • Arotinolol
  • Doxofylline
  • Racepinephrine
  • Dihydroergocornine
  • DL-Methylephedrine
  • Etafedrine
  • Tulobuterol
  • Levosalbutamol
  • Dihydroergocristine
  • Methoxyphenamine
  • Asthma
CNTF ciliary neurotrophic factor
  • IL-6-type cytokine receptor ligand interactions
ERAP1 endoplasmic reticulum aminopeptidase 1
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
IL6 interleukin 6
  • Interleukin-6 signaling
  • MAPK3 (ERK1) activation
  • MAPK1 (ERK2) activation
  • Senescence-Associated Secretory Phenotype (SASP)
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • Transcriptional Regulation by VENTX
  • Post-translational protein phosphorylation
  • ADORA2B mediated anti-inflammatory cytokines production
  • CD163 mediating an anti-inflammatory response
  • Ginseng
  • YSIL6
  • VX-702
  • Atiprimod
  • CRx-139
  • Andrographolide
  • Siltuximab
  • Polaprezinc
  • Foreskin fibroblast (neonatal)
  • Foreskin keratinocyte (neonatal)
  • Binimetinib
  • Dilmapimod
  • Olokizumab
  • Graft-versus-host disease
IL6ST interleukin 6 cytokine family signal transducer
  • Interleukin-6 signaling
  • Interleukin-6 signaling
  • IL-6-type cytokine receptor ligand interactions
  • Interleukin-35 Signalling
  • Interleukin-27 signaling
  • Interleukin-27 signaling
MAGI1 membrane associated guanylate kinase, WW and PDZ domain containing 1
SGTB small glutamine rich tetratricopeptide repeat co-chaperone beta
SRC SRC proto-oncogene, non-receptor tyrosine kinase
  • Signaling by ERBB2
  • Nuclear signaling by ERBB4
  • Downregulation of ERBB4 signaling
  • PIP3 activates AKT signaling
  • GAB1 signalosome
  • Downstream signal transduction
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Integrin signaling
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • p130Cas linkage to MAPK signaling for integrins
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • DCC mediated attractive signaling
  • DCC mediated attractive signaling
  • Netrin mediated repulsion signals
  • Regulation of commissural axon pathfinding by SLIT and ROBO
  • RAF activation
  • MAP2K and MAPK activation
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • MET activates PTK2 signaling
  • InlA-mediated entry of Listeria monocytogenes into host cells
  • Regulation of RUNX1 Expression and Activity
  • RUNX2 regulates osteoblast differentiation
  • Regulation of RUNX3 expression and activity
  • Extra-nuclear estrogen signaling
  • RHOU GTPase cycle
  • Activated NTRK2 signals through FYN
  • Activated NTRK3 signals through PI3K
  • Activated NTRK3 signals through PI3K
  • Long-term potentiation
  • GPER1 signaling
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Signaling by CSF1 (M-CSF) in myeloid cells
  • Degradation of CDH1
  • Dasatinib
  • RU84687
  • RU79256
  • N6-Benzyl Adenosine-5'-Diphosphate
  • RU85493
  • RU78262
  • Phosphonotyrosine
  • Malonic acid
  • RU83876
  • RU90395
  • RU79072
  • RU78783
  • 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
  • PASBN
  • 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid
  • PAS219
  • DPI59
  • RU82197
  • Phenylphosphate
  • RU78300
  • RU79073
  • RU82209
  • ISO24
  • RU85053
  • RU78299
  • Oxalic Acid
  • RU78191
  • Citric acid
  • Paratoulene phosphate
  • 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
  • Purvalanol A
  • XL228
  • Tirbanibulin
  • Bosutinib
  • 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
  • 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
  • 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
  • PD-168393
  • [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
  • PP-121
  • 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
  • 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
  • N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
  • (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
  • Ponatinib
  • Nintedanib
  • Fostamatinib
STAT3 signal transducer and activator of transcription 3
  • Interleukin-6 signaling
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • Interleukin-7 signaling
  • Interleukin-7 signaling
  • Signaling by SCF-KIT
  • Signaling by cytosolic FGFR1 fusion mutants
  • Downstream signal transduction
  • Signalling to STAT3
  • Signaling by ALK
  • Senescence-Associated Secretory Phenotype (SASP)
  • Signaling by Leptin
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Association of TriC/CCT with target proteins during biosynthesis
  • Transcriptional regulation of pluripotent stem cells
  • Interleukin-10 signaling
  • Interleukin-4 and Interleukin-13 signaling
  • PTK6 Activates STAT3
  • PTK6 Activates STAT3
  • Interleukin-20 family signaling
  • MET activates STAT3
  • MET activates STAT3
  • Interleukin-15 signaling
  • Interleukin-35 Signalling
  • Interleukin-9 signaling
  • Interleukin-37 signaling
  • Interleukin-23 signaling
  • Interleukin-23 signaling
  • Interleukin-27 signaling
  • Interleukin-21 signaling
  • Transcriptional regulation of granulopoiesis
  • Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants
  • Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants
  • Signaling by PDGFRA extracellular domain mutants
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF1 (M-CSF) in myeloid cells
  • STAT3 nuclear events downstream of ALK signaling
  • Inactivation of CSF3 (G-CSF) signaling
  • Cytoprotection by HMOX1
  • Signaling by ALK fusions and activated point mutants
  • Nuclear events stimulated by ALK signaling in cancer
  • Growth hormone receptor signaling
  • PKR-mediated signaling
  • Regulation of PD-L1(CD274) transcription
  • ENMD-1198
  • OPB-111077
  • Oral cancer
  • Other well-defined immunodeficiency syndromes, including the following seven diseases: Wiskott-Aldrich syndrome; DiGeorge syndrome; Hyper-IgE syndrome; X-linked lymphoproliferative syndrome; Immunodeficiency, Polyendocrinopathy, Enteropathy, X-linked Syndrome (IPEX); Cartilage-Hair Hypoplasia; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
WWP1 WW domain containing E3 ubiquitin protein ligase 1
  • Downregulation of ERBB4 signaling
  • Stimuli-sensing channels
  • Regulation of RUNX2 expression and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
WWP2 WW domain containing E3 ubiquitin protein ligase 2
  • Regulation of PTEN stability and activity
  • RHOQ GTPase cycle
  • RHOJ GTPase cycle
  • RHOU GTPase cycle
  • NOTCH3 Activation and Transmission of Signal to the Nucleus

Page 1 out of 1 pages